Deadline: 3 October 2018
Applications are open for Biomedical Catalyst 2018 Round 2: Primer Award to support the development of innovative healthcare products, technologies and processes. These can include:
- disease prevention and proactive management of health and chronic conditions
- earlier and better detection and diagnosis of disease, leading to better patient outcomes
- tailored treatments that either change the underlying disease or offer potential cures
Funding Information
- The projects to range in size from £200,000 to £1.5 million (total project costs).
- Projects should last 12 to 24 months and must start by 1 April 2019.
Eligibility Criteria
- An SME business can:
- take part in up to 3 applications in this competition round, although applicant may only be the lead partner in one application in this round
- lead only one active project in any one Biomedical Catalyst award at any time
- The exception to the rule on leading only one active project is when a new project is a direct progression from one award to the next category of awards. For example, applicant may already hold both an early stage and a late stage award. When the early stage project finishes, applicant may apply in this round for a late stage award to continue that specific programme of work while still holding applicants original late stage award. It will ask applicant to provide evidence that applicant have enough resources to run 2 projects at the same time.
How to Apply
Applications must be submitted via given website.
For more information, please visit Biomedical Catalyst 2018.
